PharmacyCodes



Ceftazidimum [INN-Latin] en es it fr

Ceftazidimum [INN-Latin] Brand names, Ceftazidimum [INN-Latin] Analogs

Ceftazidimum [INN-Latin] Brand Names Mixture

  • No information avaliable

Ceftazidimum [INN-Latin] Chemical_Formula

C22H22N6O7S2

Ceftazidimum [INN-Latin] RX_link

http://www.rxlist.com/cgi/generic2/ceftaz.htm

Ceftazidimum [INN-Latin] fda sheet

Ceftazidimum_[INN-Latin] FDA

Ceftazidimum [INN-Latin] msds (material safety sheet)

Ceftazidimum_[INN-Latin] MSDS

Ceftazidimum [INN-Latin] Synthesis Reference

No information avaliable

Ceftazidimum [INN-Latin] Molecular Weight

546.578 g/mol

Ceftazidimum [INN-Latin] Melting Point

No information avaliable

Ceftazidimum [INN-Latin] H2O Solubility

396 mg/L

Ceftazidimum [INN-Latin] State

Solid

Ceftazidimum [INN-Latin] LogP

-1.60

Ceftazidimum [INN-Latin] Dosage Forms

Powder; Powder for solution

Ceftazidimum [INN-Latin] Indication

For the treatment of patients with infections caused by susceptible strains of organisms in the following diseases: lower respiratory tract infections,skin and skin structure infections, urinary tract infections, bacterial septicemia, bone and joint infections, gynecologic infections, intra abdominal infections (including peritonitis), and central nervous system infections (including meningitis).

Ceftazidimum [INN-Latin] Pharmacology

Ceftazidime is a semisynthetic, broad-spectrum, beta-lactam antibiotic for parenteral administration. Ceftazidime is bactericidal in action exerting its effect by inhibition of enzymes responsible for cell-wall synthesis. A wide range of gram-negative organisms is susceptible to ceftazidime in vitro, including strains resistant to gentamicin and other aminoglycosides. In addition, ceftazidime has been shown to be active against gram-positive organisms. It is highly stable to most clinically important beta-lactamases, plasmid or chromosomal, which are produced by both gram-negative and gram-positive organisms and, consequently, is active against many strains resistant to ampicillin and other cephalosporins. Ceftazidime has activity against the gram-negative organisms Pseudomonas and Enterobacteriaceae. Its activity against Pseudomonas is a distinguishing feature of ceftazidime among the cephalosporins.

Ceftazidimum [INN-Latin] Absorption

The absorption of ceftazidime is directly proportional to the size of the dose.

Ceftazidimum [INN-Latin] side effects and Toxicity

Ceftazidime overdosage has occurred in patients with renal failure. Reactions have included seizure activity, encephalopathy, asterixis, neuromuscular excitability, and coma.

Ceftazidimum [INN-Latin] Patient Information

No information avaliable

Ceftazidimum [INN-Latin] Organisms Affected

Enteric bacteria and other eubacteria